pfizervaccine

Data on the fourth Covid shot will be submitted to the FDA soon said Pfizer’s CEO

According to Pfizer Inc. Chief Executive Officer Albert Bourla, the company will shortly submit data to US authorities on a…

3 years ago

New York state data on Pfizer/BioNTech vaccine has EMA unconcerned

The chief vaccine specialist at the European Medicines Agency said he was unconcerned by new data from New York state…

3 years ago

Regional leaders of Pfizer claim Omicron vaccine to be ready in less than 2 months

Pfizer's regional leaders in Africa and the Middle East, AfME, have stated that their Omicron-specific vaccination would be available in…

3 years ago

Pfizer-BioNTech, Moderna, and Oxford-efficacy AstraZeneca’s COVID-19 vaccinations are effective at preventing SARS-CoV-2 infection

Millions of people died around the world as a result of the coronavirus illness (COVID-19) pandemic. Non-pharmaceutical interventions were initially…

3 years ago

Pfizer: COVID pill’s results, potency versus Omicron

Pfizer said on Tuesday that its COVID-19 experimental tablet appeared to be effective against the Omicron variety. The business also…

3 years ago

Combining Pfizer and AstraZ COVID-19 injections with Moderna improves immunological response – UK research

According to the findings of a large British trial on the combination of COVID-19 vaccinations, participants had a greater immune…

3 years ago

“Already Working” on vaccine targeting Covid vaccine: Pfizer

In the event that the present inoculation is ineffective against the new strain, Pfizer has already begun developing a version…

3 years ago

Pfizer requesting emergency approval in United States for COVID-19 pill

According to CEO Albert Bourla, the tablet might significantly reduce fatalities and hospitalizations. The Biden administration is expected to declare…

3 years ago

Pfizer’s Covid vaccination booster is available in Canada for adults

For persons aged 18 and above, Canada approved the use of the booster dose of the Covid vaccine, which was…

3 years ago

New COVID-19 pill cut hospital, death risk by 90%: Pfizer

Pfizer Inc. said on Friday that its experimental antiviral pill for COVID-19 reduced hospitalisation and death rates by nearly 90%,…

3 years ago